← 返回

肿瘤内具有组织驻留记忆表型的 CD8(+) T 细胞在乳腺癌中介导局部免疫和免疫检查点应答

英文原题:Intratumoral CD8(+) T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer.

查看英文原题

Intratumoral CD8(+) T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer.

PubMed 2023/02/23(内容时间) Cancer Cell Q1 · IF 56.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

具有组织驻留记忆T(T RM)细胞表型的CD8 + TIL(肿瘤浸润淋巴细胞)与三阴性乳腺癌(TNBC)患者的良好预后相关。然而,CD8 + T RM细胞对抗肿瘤免疫和乳腺癌免疫检查点阻断疗效的相对贡献仍不清楚。在此,我们表明,小鼠乳腺肿瘤中的瘤内CD8 + T细胞在转录水平上与TNBC患者的相似。表型和转录研究确定了两个瘤内亚群:一个更富集终末耗竭标志物(T EX样),另一个具有真正的驻留表型(T RM样)。抗PD-1和抗CTLA-4治疗导致这些瘤内群体扩增,其中T RM样亚群显示出显著增强的细胞毒性能力。T RM样CD8 + T细胞还可提供局部免疫保护以抵抗肿瘤再挑战,并且从无肿瘤组织中提取的T RM基因特征与接受检查点抑制剂治疗的TNBC患者临床结局改善显著相关。

展开英文摘要原文

CD8 + tumor-infiltrating lymphocytes with a tissue-resident memory T (T RM ) cell phenotype are associated with favorable prognosis in patients with triple-negative breast cancer (TNBC).

However, the relative contribution of CD8 + T RM cells to anti-tumor immunity and immune checkpoint blockade efficacy in breast cancer remains unknown.

Here, we show that intratumoral CD8 + T cells in murine mammary tumors transcriptionally resemble those from TNBC patients. Phenotypic and transcriptional studies established two intratumoral sub-populations: one more enriched in markers of terminal exhaustion (T EX -like) and the other with a bona fide resident phenotype (T RM -like).

Treatment with anti-PD-1 and anti-CTLA-4 therapy resulted in expansion of these intratumoral populations, with the T RM -like subset displaying significantly enhanced cytotoxic capacity. T RM -like CD8 + T cells could also provide local immune protection against tumor rechallenge and a T RM gene signature extracted from tumor-free tissue was significantly associated with improved clinical outcomes in TNBC patients treated with checkpoint inhibitors.

论文信息

作者
Virassamy B、Caramia F、Savas P、Sant S、Wang J、Christo SN、Byrne A、Clarke K
第一作者单位
Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.Australia
通讯作者单位
Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; The Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Melbourne, VIC, Australia. Electronic address: sherene.loi@petermac.org.Australia
文献类型
非美国政府资助研究
期刊
Cancer cell2023 Mar 13
原文标识
PubMed 36827978 · DOI 10.1016/j.ccell.2023.01.004